CHM chimeric therapeutics limited

Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial, page-40

  1. 1,734 Posts.
    lightbulb Created with Sketch. 543
    The challenge for CHM is getting up enough speed to exit the death spiral.

    I think our MC has become so ridiculously low simply due to funding concerns.

    You'd hope that this hugely dilutive raise will give us the runway and momentum required to get significant results and rerate in before the next raise. Tough ask.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
-0.001(12.5%)
Mkt cap ! $11.37M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $11.47K 3.312M

Buyers (Bids)

No. Vol. Price($)
67 44357315 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 99617122 29
View Market Depth
Last trade - 10.45am 07/08/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.